Company news

Spruce Biosciences, Inc. news in 2021

Spruce Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Spruce Biosciences Appoints Mike Grey as Interim CEO

November 14, 2021

Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day

August 24, 2021

Spruce Biosciences to Host Virtual R&D Day on August 25, 2021

August 10, 2021

Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates

August 9, 2021

Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors

June 23, 2021

Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism

June 20, 2021

Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates

May 11, 2021

Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates

March 21, 2021

Spruce Biosciences Provides Corporate Update and Outlines Milestones for 2021

January 5, 2021

Decks in 2021